EN CN
EN CN

2018/11/06 00:00

PREVIOUS ARTICLE CANbridge Life Sciences Receives Approval to Commence CAN017 Ib/III Trial in Esophageal Squamous Cell Cancer (ESCC) In China NEXT ARTICLE